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Phage G1 gp67 is a 23 kDa protein that binds to
the Staphylococcus aureus (Sau) RNA polymerase
(RNAP) sA subunit and blocks cell growth by inhibit-
ing transcription. We show that gp67 has little to no
effect on transcription from most promoters but is
a potent inhibitor of ribosomal RNA transcription. A
2.0-A˚-resolution crystal structure of the complex
between gp67 and Sau sA domain 4 (sA4) explains
how gp67 joins the RNAP promoter complex through
sA4 without significantly affecting s
A
4 function. Our
results indicate that gp67 forms a complex with
RNAP at most, if not all, sA-dependent promoters,
but selectively inhibits promoters that depend on
an interaction between upstream DNA and the
RNAP a-subunit C-terminal domain (aCTD). Thus,
we reveal a promoter-specific transcription inhibition
mechanism by which gp67 interacts with the RNAP
promoter complex through one subunit (sA), and
selectively affects the function of another subunit
(aCTD) depending on promoter usage.
INTRODUCTION
Staphylococcus aureus (Sau) is a pathogenic Gram-positive
bacterium that causes infections of the skin as well as pneu-
monia, meningitis, endocarditis, and sepsis (Lowy, 1998). Meth-
icillin-resistant Sau (MRSA) infections have become increasingly
common and lead to significant morbidity and mortality (Nord-
mann et al., 2007). MRSA strains were recently reported to
also be resistant to vancomycin, the current antibiotic of last
resort (Howden et al., 2010), highlighting the importance of
discovering novel therapeutics that inhibit Sau growth.
Before the advent of modern antibiotics, bacteriophages
(phages) were considered potential therapeutic agents because
of their ability to kill specific bacterial species rapidly. As
microbes become increasingly resistant to antibiotics, phages
are once again being exploited for their ability to directly elimi-Cnate bacterial infections and provide novel targets for the drug
discovery process (Fischetti, 2008).
Recent studies have mined phage genomes for proteins and
peptides that inhibit Sau cell growth (Kwan et al., 2005; Liu
et al., 2004). One such protein, phage G1 gp67 (encoded by
orf67), inhibits cell growth when produced in Sau, but not in
Escherichia coli (Eco), and was shown to significantly decrease
RNA production in Sau (Liu et al., 2004). Subsequent work
demonstrated a direct interaction between gp67 and Sau RNA
polymerase (RNAP; Dehbi et al., 2009).
All transcription in prokaryotes is performed by the 400 kDa
core RNAP (subunit composition a2bb
0u; Darst, 2001). Pro-
moter recognition and initiation require an additional subunit,
s, which binds to the core RNAP to form the holoenzyme
(Murakami and Darst, 2003). The group 1, or primary, s factors
(s70 in Eco, sA in Sau) are responsible for the bulk of transcrip-
tion during log-phase growth and are essential for viability
(Gruber and Gross, 2003). In the context of the RNAP holoen-
zyme, the structural domains of sA directly recognize conserved
core promoter elements: domain 2 of sA (sA2) recognizes
the 10 element, and sA4 recognizes the 35 element (Camp-
bell et al., 2002; Feklistov and Darst, 2011; Murakami et al.,
2002a; Shultzaberger et al., 2007). Promoters may contain addi-
tional elements recognized by s, such as the extended 10
(Keilty and Rosenberg, 1987) or discriminator element (Feklistov
et al., 2006; Haugen et al., 2008b; Travers, 1984). In addition,
certain promoters are dependent on an A/T-rich DNA sequence
upstream of the 35 element, known as the UP element (Ross
et al., 1993). The UP element is recognized by the 9 kDa
C-terminal domains of the RNAP a subunits (aCTDs), which
are attached to the a-N-terminal domains by 15-residue-
long, flexible unstructured linkers (Blatter et al., 1994; Gourse
et al., 2000).
Previous biochemical analyses established that gp67I (1) inter-
acts directly with Sau sA but not Eco s70, (2) uses sA4 as its pri-
mary interaction determinant, and (3) forms a stable, ternary
gp67/Sau-sA/Sau-core-RNAP complex (Dehbi et al., 2009).
Using the lPL promoter with a hybrid system comprising Sau
sA with Eco core RNAP, as well as Sau-sA/Sau-core-RNAP,
Dehbi et al. (2009) concluded that gp67 is a Sau sA-specific
anti-s factor that blocks sA4 recognition of the 35 elementell 151, 1005–1016, November 21, 2012 ª2012 Elsevier Inc. 1005
Figure 1. Gp67 Inhibits Transcription by the Sau RNAP Holoenzyme
but Not the Eco RNAP Holoenzyme or the Hybrid Holoenzyme
Sau-sA/Eco-core RNAP
Values represent the mean of three independent experiments, and error bars
denote the mean ± 1 SD.
See also Figure S1.and is therefore a general inhibitor of 35 element-dependent
promoters.
Here, we demonstrate that gp67 is a promoter-specific tran-
scription inhibitor. Gp67 does not inhibit transcription from
the majority of Sau promoters, but is a potent inhibitor of ribo-
somal RNA (rRNA) transcription in vitro and in vivo. Using X-ray
crystal structures of gp67 bound to Sau sA4, in vivo RNA
sequencing (RNA-seq) analysis, and in vitro biochemical anal-
yses, we show that gp67 interferes with binding of the aCTDs
to DNA upstream of the promoter 35 element, and therefore
inhibits promoters that depend on the aCTD/DNA interaction.
Gp67 is a phage-encoded transcription factor that acts through
a novel mechanism in which it joins the RNAP holoenzyme
through sA4 but modulates the host transcription program by
interfering with promoter DNA interactions of the aCTDs.
RESULTS
Gp67 Function Requires a Native Sau Transcription
System
In contrast to Sau RNAP, Eco RNAP is well characterized bio-
chemically, and numerous tools such as mutant and modified
Eco RNAPs are available for probing mechanistic questions.
Therefore, as a first step toward understanding the molecular
mechanism through which gp67 inhibits RNAP, we sought to
reproduce the results of Dehbi et al. (2009) using the hybrid tran-
scription system of Sau sA with Eco core RNAP on the lPL
promoter. In contrast to Dehbi et al. (2009), we did not observe
any effect of gp67 on lPL transcription, even when gp67 was
at a 100-fold molar excess over the hybrid holoenzyme (Fig-
ure S1A available online). Moreover, a native gel-shift analysis re-
vealed that gp67 formed a ternary gp67/Sau-sA/Sau-core-RNAP
complex (Figure S1B, lane 3) but did not interact with the hybrid
Sau-sA/Eco-core-RNAP (Figure S1C, lane 1).
Because gp67 failed to inhibit or even interact with the hybrid
holoenzyme, we purifiedSau core RNAP (Deora andMisra, 1996)
and optimized the in vitro transcription conditions (see Experi-
mental Procedures). Few Sau promoters have been character-
ized in vitro, so we first investigated Sau RNAP-holoenzyme
activity in vitro using Sau genomic DNA as a template. Gp67 in-
hibited promoter-specific Sau RNAP-holoenzyme transcription
from Sau genomic DNA (Figure 1, red bars), but did not inhibit1006 Cell 151, 1005–1016, November 21, 2012 ª2012 Elsevier Inc.transcription by the hybrid holoenzyme Sau-sA/Eco-RNAP (Fig-
ure 1, blue bars) or by Eco RNAP holoenzyme (Figure 1, orange
bars), consistent with our in vitro results on the lPL promoter
(Figure S1A). To determine whether inhibition of Sau RNAP
holoenzyme by gp67 was dependent on the Sau-sA/gp67 inter-
action, we used a bacterial two-hybrid assay (Dove and Hochs-
child, 2004) to generate an otherwise functional sA mutant that
could no longer interact with gp67 (Figure S1D). We found that
gp67 was unable to inhibit transcription by the corresponding
mutant Sau holoenzyme (Figure 1, green bars). Gp67 inhibition
therefore requires a native Sau transcription system.
Gp67 Inhibits rRNA Synthesis In Vitro and In Vivo
Phage promoters have been important tools for studying RNAP
function (Kadesch et al., 1982; Rosenberg et al., 1982; Stevens,
1977). The genome of the Sau-specific G1 phage has many
easily identifiable promoters that closely match the 10/35
consensuses with the optimal 17 bp spacing between them
(Shultzaberger et al., 2007). One such promoter is G1-pORF05
(Figure 2A). Sau RNAP-holoenzyme has robust activity from
this promoter when tested in vitro, but gp67 has no effect on
this activity even at very high concentrations (Figure 2B).
Because gp67 does not inhibit this 10/35 promoter, it is
unlikely that gp67 blocks recognition of the 35 element as
previously proposed (Dehbi et al., 2009).
Gp67 inhibits bulk RNA synthesis in vivo (Liu et al., 2004) and
in vitro (Figure 1). Because the major fraction of transcription in
growing bacterial cells is dedicated to ribosome synthesis
(Gourse et al., 1996), we examined the effect of gp67 on tran-
scription from three Sau rRNA promoters: rrnA, rrnB-P1, and
rrnB-P2 (Figure 2A). Gp67 is a potent inhibitor of in vitro tran-
scription from these Sau rRNA promoters, and the inhibition
depends on the interaction between gp67 and RNAP (Figure 2B).
To test whether gp67 inhibits rRNA synthesis in vivo, we
expressed gp67 in Sau cells using an inducible expression vec-
tor (Corrigan and Foster, 2009). Upon addition of inducer, cell
growthwas slowed but not halted by gp67 expression (Figure S2)
and rRNA levels remained unchanged (Figure 2C). Whereas
messenger RNAs (mRNAs) generally have short half-lives in vivo,
rRNAs are stable in prokaryotic cells (Deutscher, 2003). There-
fore, to assess the effect of gp67 expression on rRNA synthesis,
we used metabolic labeling to observe newly transcribed RNAs.
Gp67 was expressed in Sau cells, and then newly synthesized
RNAs were labeled by addition of radiolabeled phosphate to
the growth medium (Wade et al., 1964). Whereas gp67 had little
to no effect on the overall rRNA levels (Figures 2C and 2D, left
panel), gp67 production significantly reduced new rRNA syn-
thesis (Figure 2D, right panel). These data indicate that gp67
inhibits RNAP activity at rRNA promoters, but the rRNAs remain
stable in the cells for hours after gp67 production. We conclude
that gp67 is not a general inhibitor of Sau sA holoenzyme, but is
a potent and direct inhibitor of rRNA transcription in vitro (Fig-
ure 2B) and in vivo (Figure 2D).
RNA-seq Reveals Promoters Inhibited by gp67 on
a Genome-wide Scale
Because gp67 appears to be a promoter-specific inhibitor of
Sau transcription, we wanted to determine the effect of gp67
Figure 2. Gp67 Inhibits rRNA Synthesis In Vitro and In Vivo
(A) Sequences of promoters used in subsequent experiments.
(B) Gp67 inhibits RNAP activity at Sau rrn promoters but not at a G1 phage 10/35 promoter (pORF05). The indicated bands were quantified by phosphor-
imagery; relative activity (versus holoenzyme alone) is denoted below each lane.
(C) Gp67 does not significantly decrease rRNA abundance in vivo. Cellular RNAwas purified from 23 108SauRN4220 cells at different times after the induction of
gp67 synthesis. The Sau s is either wild-type (WT) or the mutant (M) unable to interact with gp67 (Figure S1D).
(D) Gp67 inhibits synthesis of rRNA in vivo. Inducer was added to SauRN4220 cells containing pRMC2 or pRMC2-gp67, and newly synthesized RNAwas labeled
by the addition of [32P]-orthophosphoric acid to the growth medium. RNAwas purified from 23 108 pRMC2 and pRMC2-gp67 cells, run on a 6% urea-PAGE gel,
stained with GelRed to visualize all RNAs (left), and visualized by phosphorimagery (right).
See also Figure S2.on a wide variety of promoters in order to understand the
characteristics that lead to gp67 sensitivity. For this pur-
pose, we used RNA-seq to quantitatively compare RNA
transcripts from Sau cells grown in the absence or presence
of gp67. RNA was purified from Sau RN4220 cells pro-
ducing gp67 as well as from control cells (Figure S2C), rRNAs
were depleted, and libraries were prepared by standard pro-
cedures. The RNA was then sequenced by Illumina tech-
nology. We found that gp67 had no effect on transcriptionCfrom the majority of promoters in the Sau genome (Figure 3A).
Less than 4% of all transcripts were downregulated, and
5% were upregulated by gp67 production during the growth
phase.
RNA-seq only reveals RNA transcript levels; it does not differ-
entiate between direct and indirect regulation of gene expres-
sion, nor does it reveal whether differential gene expression is
due to changes in promoter binding and initiation or mRNA
stability. We used the Sau in vitro transcription system to testell 151, 1005–1016, November 21, 2012 ª2012 Elsevier Inc. 1007
Figure 3. RNA-seq Reveals Promoters that Are Sensitive to gp67 Inhibition In Vivo
(A) Gp67 production inSauRN4220 cells does not significantly inhibit RNA levels from91%of promoters. RNAswere sequenced directly and visualized with the
Integrated Genomics Viewer. The position on the genome is shown on the horizontal axis, and the number of RNA reads per million total reads is shown on the
vertical axis. Upper panel (green) represents RNA-seq data from pRMC2-gp67 cells; the lower panel (red) represents RNA-seq data from control pRMC2 cells.
(B) Gp67 production does not inhibit transcription from selected DNA replication promoters in vivo. RNA-seq data were visualized as above from the dnaA, aag,
and polIII loci.
1008 Cell 151, 1005–1016, November 21, 2012 ª2012 Elsevier Inc.
Figure 4. Cocrystal Structure of gp67/sA4
(A) Cocrystal structure of gp67 bound to sA4
(orange). Two orthogonal views are shown. Pro-
teins are shown in ribbon format.
(B) Structural modeling indicates that the RNAP
b-flap-tip/sA4 interaction is compatible with the
presence of gp67. Gp67 is shown as a molecular
surface, color-coded as in (A). The sA4 is shown
as a light orange ribbon. The RNAP b-flap-tip,
modeled by superimposing sA4 from the Thermus
aquaticus RNAP holoenzyme (Murakami et al.,
2002b), is shown as a light blue ribbon with a
transparent molecular surface (cyan).
(C) Gp67 does not contact most residues of sA4
that interact with 35-element DNA. Shown is
a close-up view of Sau sA4 (light orange ribbon) in
the complex with gp67 (molecular surface, color-
coded as in [A]). Side chains of residues that
directly interact with35-element DNA are shown
from the gp67/Sau sA4 structure (orange) and
from the superimposed Taq sA4/-35 element DNA
complex (green side chains; PDB ID code 1KU7;
Campbell et al., 2002). Only the side chain of Sau
sA4 R310 (corresponding to Taq s
A
4 R379/Eco s
70
R554) is altered through an interaction with gp67.
See also Figure S4 and Tables S1 and S2.whether gp67 directly affects transcription at promoters identi-
fied by RNA-seq.
DNA replication is often a target of early phage proteins (Datta
et al., 2005; Yano and Rothman-Denes, 2011). However, expres-
sion of genes involved in replication (Xu et al., 2010) was not
significantly altered in the presence of gp67 in vivo (Figure 3B).
Gp67 also did not inhibit the activity of RNAP at the dnaA or
aag (a putative DNA repair protein) promoters in vitro, and had
an effect on already weak RNAP activity at the polIII promoter
only at a very high gp67 concentration (Figure 3C). In contrast,
when tested on promoters that show significant levels of inhibi-
tion by gp67 in vivo (Figure 3D), gp67 was found to be a potent
inhibitor of transcription in vitro (Figure 3E), indicating that, at
least at these promoters, the in vivo effects are direct. Gp67
had no effect on transcript levels from Sau promoters that
were previously studied using purified in vitro transcription sys-
tems (Figure S3; Rao et al., 1995; Reyes et al., 2011). Because
gp67 had no effect on >90% of Sau promoters in vivo, or on
the G1-pORF05, dnaA, and aag promoters in vitro, gp67 must
not target general s functions, such as 10 or 35 promoter
element recognition or core RNAP interaction.
Crystal Structure of the gp67/Sau sA4 Complex
To shed light on the mechanism by which gp67 modulates Sau
RNAP function, we determined X-ray crystal structures of the
gp67/Sau-sA4 complex. We solved the structure from two(C) Gp67 does not inhibit transcription from selected DNA replication promoter
activity (versus holoenzyme alone) is denoted below each lane.
(D) Selected genes inhibited by gp67 in vivo. RNA-seq data were visualized as a
(E) Gp67 inhibits transcription in vitro from the selected promoters that are susce
that does not interact with gp67 (M). The indicated bands were quantified by ph
each lane.
See also Figures S2 and S3, and Table S3.
Ccrystal forms: form I (2.0 A˚ resolution) and form II (3.0 A˚ resolu-
tion; Tables S1 and S2; Figure S4C). Three crystallographically
independent structures did not show any significant differences
(root-mean-square deviation [rmsd] of a-carbon positions = %
0.78 A˚). Therefore, we derived all of the structural analyses
using the high-resolution form I structure. Although the struc-
ture of s4 has been well described (Campbell et al., 2002),
gp67 has no sequence or structural homology to any previously
described fold.
The 2.0 A˚ crystal structure reveals the nature of the interac-
tions between gp67 and sA4 (Figures 4A, S4D, and S4E). The
sA4 has been studied structurally in many contexts, including
bound to DNA (Campbell et al., 2002), RNAP (Murakami et al.,
2002b; Vassylyev et al., 2002), RNAP and DNA (Murakami
et al., 2002b), and anti-s factors (Campbell et al., 2008). Gp67
does not reorganize the conformation of sA4 (Figures 4A and
S4F), as occurs in some anti-s/s complexes (Campbell et al.,
2007; Lambert et al., 2004).
Gp67 itself comprises two domains: an N-terminal b-sheet-
rich domain (gp67-NTD; Figure 4A, teal) and a C-terminal
a-helical domain (gp67-CTD; Figure 4A, blue). The two domains
are connected by a linker-a-helix on the surface of gp67 oppo-
site the sA4 interaction surface (gp67-linker; Figure 4A, gray).
Gp67 forms an extensive molecular interface with sA4 through
both the gp67-NTD (1,032 A˚2 buried surface area) and the
gp67-CTD (1,757 A˚2 buried surface area), with a total burieds in vitro. The indicated bands were quantified by phosphorimagery; relative
bove from the csp1, csp2, and pstp loci.
ptible in vivo when wild-type (WT) sA is used, but not the quadruple mutant sA
osphorimagery; relative activity (versus holoenzyme alone) is denoted below
ell 151, 1005–1016, November 21, 2012 ª2012 Elsevier Inc. 1009
Figure 5. Structural Model of the gp67/RNAP Holoenzyme/Open Promoter Complex
(A) Overall view. The core RNAP is shown as a molecular surface (b’, pale pink; b, pale cyan). The sA subunit is shown as a molecular surface (sA2 and s
A
3, pale
orange) or a ribbon (sA4, orange). Gp67 is shown as a blue ribbon. One aCTD is shown (yellow ribbon) bound to the proximal UP-element subsite, modeled as
described in Jain et al. (2005). The DNA is shown as a phosphate-backbone worm, with the promoter35 element in yellow and the proximal UP-element subsite
(Estrem et al., 1998, 1999) in magenta. The boxed region is magnified in (B).
(B) Magnified view of the35-element/proximal UP-element region. Shown as in (A). The green sphere denotes a Zn2+ ion. The DNA is numbered with respect to
the Sau rrnA promoter start site (see Figure 6A). The schematic at the lower right shows the 35-element/UP-element region of the Sau rrnA promoter. The
regions of close protein/DNA interaction for sA4 (orange), gp67 (blue), and aCTD (yellow) are denoted by the span of the boxes.
(C) View toward the gp67/sA4 DNA interaction surface. The RNAP is shown in ribbon format. Themolecular surface of the gp67/s
A
4 complex is colored according
to the electrostatic surface distribution (red, 5 kT; white, neutral; blue, +5 kT). The region corresponding to sA4 is outlined in orange.
See also Figure S4 and Tables S1 and S2.surface area of 2,789 A˚2. Based on the results of our two-hybrid
analysis, we identified a limited number of amino acid differ-
ences between Sau sA4 and Eco s
70
4 that determine the speci-
ficity of gp67 binding (Figure S1D). In accord with this genetic
analysis, the identified residues (Sau sA D309, E312, N313,
and V335) all participate in the gp67/sA interface (Figures S4D
and S4E).
Most anti-s factors bind their cognate s factor and block at
least one of the main s functions: core RNAP binding and/or
core promoter element recognition (Campbell et al., 2008;
Lambert et al., 2004; Patikoglou et al., 2007). Gp67 does not
prevent core RNAP binding of Sau sA (Figure S1B), and our
finding that gp67 does not inhibit transcription from the vast
majority of Sau 10/35 promoters in vivo (Figure 3A) is incon-
sistent with a model in which gp67 blocks recognition of the
35 element by sA4. Indeed, structural modeling, as described
below, suggests that core RNAP binding and 35 element
DNA binding by sA4 would be allowed in the complex with
gp67 (Figures 4B and 4C).
The sA4 binds to core RNAP primarily through an interaction
with the b-flap-tip-helix, a structural element of the RNAP
b subunit. ThesA4/b-flap-tip-helix interaction is essential to posi-
tion sA4 in the proper orientation and spacing for 35 element
recognition (Kuznedelov et al., 2002; Murakami et al., 2002b).
One can superimpose the b-flap-tip from the RNAP holoenzyme
(Murakami et al., 2002b) on the gp67/sA4 structure (by superim-
posing the sA4 structural core) without introducing any steric
clashes with gp67 (Figure 4B).
Ten highly conserved residues of sA4 make direct contact
with 35 element DNA (Campbell et al., 2002; Jain et al., 2004).1010 Cell 151, 1005–1016, November 21, 2012 ª2012 Elsevier Inc.All but one of these DNA-contacting residues of sA4 are unper-
turbed by gp67 and do not make any contacts with gp67 (Fig-
ure4C). Theoneexception isSausA4Arg310 (whichcorresponds
to Taq sA Arg379/Eco s70 Arg554). In the 35 element-bound
complex, this Arg residue interacts with the DNA phosphate
backbone at the 36 position just upstream of the 35 element
(Campbell et al., 2002; Jain et al., 2004). In the gp67 complex,
Sau sA4 Arg310 is redirected away from the DNA-binding inter-
face and is buried in a deep pocket of gp67 (Figure 4C) where it
makes extensive interactions with gp67 residues.
Using either the Taq sA4/-35 element DNA complex struc-
ture (Protein Data Bank [PDB] ID code 1KU7; Campbell et al.,
2002) or an RNAP-holoenzyme open promoter complex (RPo)
model to superimpose 35 element DNA on the gp67/sA4
structure reveals minor steric clashes (Figure 5). Nevertheless,
based on the following points, we argue that gp67 binding to
sA4 does not significantly affect recognition of the35 promoter
element by sA4, and may introduce additional protein/DNA
interactions:
1. Our in vitro and in vivo results indicate that gp67 is not
a general inhibitor of 10/35 promoters (Figures 2B
and 3A–3C).
2. The minor steric clash with the DNA is at the distal
end of the gp67-CTD helical tower, which has relatively
high B-factors and is likely to be conformationally flexi-
ble. A small rearrangement of the end of the gp67-CTD
helical tower and/or the DNA could relieve the clash and
appears to facilitate an interaction in the DNA major
groove.
Figure 6. Gp67 Blocks UP-Element Utilization
(A) Schematic of promoters used in swapping and footprinting experiments.
DNA positions for the rrnA and dnaA promoters are labeled relative to the start
site (+1). The10 and35 elements are shaded red. The putative UP-element
region of the rrnA promoter is shaded green. The corresponding region of the
dnaA promoter is denoted by red text.
(B) The region upstream of the 35 element is required for gp67 inhibition.
In vitro transcription assays were performed from hybrid promoters con-
structed by swapping the region upstream of the 35 element between the
rrnA (gp67-sensitive) and dnaA (gp67-resistant) promoters.
(C) DNase I footprinting. Left panel: Sau rrnA promoter with EcoRNAP and Eco
RNAP-DaCTD. Middle panel: Sau rrnA promoter with Sau RNAP holoenzyme
(±gp67). Right panel: Sau dnaA promoter with Sau RNAP holoenzyme (±gp67).
See also Figure S5.3. The molecular surface of gp67 that faces the DNA in
our model is very basic, particularly upstream of the 35
element (Figure 5C).
In summary, the 2-A˚-resolution X-ray crystal structure of the
gp67/Sau-sA4 complex, combined with structural modeling,
reveals that gp67 bound to sA4 would not interfere with s
A
4
binding to RNAP (Figure 4B), andwould be unlikely to completely
block sA4 interactions with35-element DNA (Figures 4C and 5).
These observations are consistent with our biochemical find-
ings that gp67 forms a ternary gp67/sA/RNAP complex (Fig-
ure S1B) and does not disrupt 35-element recognition by sA4
at most 35-element-dependent promoters (Figure 3A).
Gp67 Inhibits Transcription from Promoters Containing
an A/T-Rich Sequence Upstream of the 35 Element
Because gp67 is unlikely to block35-element recognition in the
context of the RNAP holoenzyme, we hypothesized that other
promoter DNA elements may confer susceptibility to gp67 inhibi-
tion. We aligned all promoters tested in vitro for direct gp67
activity by their 10 and 35 elements (Figure S5A). The sensi-
tive promoters do not share an obvious common sequence but
tend to be A/T rich in the region upstream of the 35 element,
where an UP element would be expected (Estrem et al., 1998,
1999), whereas this characteristic was less prominent in pro-
moters resistant to gp67 inhibition (Figure S5A).
To test whether the region upstream of the 35 element was
important for gp67 function, we constructed hybrid promoters
by swapping the DNA immediately upstream of the35 element
between a gp67-sensitive promoter, rrnA, and a gp67-resistant
promoter, dnaA (Figure 6A). As observed previously, gp67 in-
hibited transcription from rrnA (Figure 6B, lanes 1 and 2). In the
absence of gp67, the hybrid rrnA(upstream dnaA) promoter
showed decreased activity, similar to the gp67-inhibited rrnA
(Figure 6B, lane 3), and gp67 had no additional effect on this
hybrid promoter (Figure 6B, lane 4). Gp67 did not significantly
affect transcription from the dnaA promoter (Figure 6B, lanes 5
and 6). However, when its upstream sequence was replaced
by the rrnA A/T-rich sequence, the resulting dnaA(upstream
rrnA) promoter became highly sensitive to gp67 (Figure 6B, lanes
7 and 8). The loss of activity between rrnA and rrnA(upstream
dnaA) (Figure 6B, lanes 1 and 3) demonstrates that the A/T-
rich sequence just upstream of the rrnA35 element contributes
significantly to rrnA activity. Moreover, these results argue that
susceptibility to gp67 inhibition is mediated by a promoter fea-
ture upstream of the 35 element, and implicate an A/T-rich
sequence in this susceptibility.
Gp67 Alters RNAP Interactions with Promoter DNA
Upstream of the 35 Element
To test whether gp67 directly modulates RNAP binding to
promoters with A/T-rich elements, we used DNase I footprinting.
DNase I cleaves at exposed minor grooves of the DNA double
helix. Cleavage is enhanced by deformations or bends in the
DNA double helix that widen the minor groove (Fox, 1997).
Because Sau rrn promoters have not been tested bio-
chemically, and UP-element binding has not been shown in
this organism, we first examined the Sau rrnA promoter byCell 151, 1005–1016, November 21, 2012 ª2012 Elsevier Inc. 1011
DNase I footprinting using Eco RNAP (Figure 6C, left panel).
Binding and distortion of the promoter DNA by Eco RNAP are
indicated by strong DNase I hypersensitive sites observed on
the template strand upon Eco RNAP binding (Figure 6C;
compare no RNAP, lane 1, with Eco RNAP, lane 2) between
the 10 and 35 elements (at 29; Figure 6C, band a) and
just upstream of the 35 element (at 40; Figure 6C, band b).
DNase I hypersensitivity in these regions is commonly observed
in Eco RNAP/promoter complexes (Ozoline and Tsyganov,
1995). We also determined the DNase I footprint of a mutant
Eco RNAP lacking the aCTDs (Eco RNAP-DCTD; Figure 6C,
lane 3) to assess the effects of the aCTD/UP-element interaction
on the cleavage pattern. In the absence of the aCTD/UP-element
interaction, DNase I hypersensitive band a was unaffected,
whereas band b was relatively much less intense. In addi-
tion, new cleavage sites appeared in the region upstream of
the 35 element, at approximately 46 and 52, in the middle
of the expected UP-element region (37 to 56; Estrem et al.,
1998; Gourse et al., 2000).
Thus, in terms of DNase I hypersensitivity, the RNAP/promoter
complex with the aCTD/UP-element interaction is characterized
by very strong hypersensitivity at band b, and an absence of
hypersensitive sites in the expected region of the UP element.
In the absence of the aCTD/UP-element interaction, band b is
much reduced and cleavage sites appear within the region of
the UP element.
The DNase I footprint of Sau RNAP on the gp67-sensitive Sau
rrnA promoter is very similar to the Eco RNAP footprint (Fig-
ure 6D, compare lanes 4 and 5) and displays the characteristics
of the aCTD/UP-element interaction (i.e., very strong hypersen-
sitivity at band b and absence of cleavage upstream). The DNase
I footprint in the presence of gp67 (Figure 6D, lane 6) is indicative
of disrupted aCTD/UP-element interactions: band a and down-
stream regions of the footprint show few changes, but upstream
of the 35 element, the hypersensitive site at 40 (band b) is
completely eliminated and hypersensitive sites appear within
the UP element (at approximately 47 and 51).
The disappearance of the hypersensitive band b in the pres-
ence of gp67 could be explained by protection of the site due
to the physical presence of gp67 (since our structural modeling
suggests that gp67 may interact with the DNA minor groove
between37 and44; Figure 5) or by an alteration of the confor-
mation of the DNA induced by gp67. In view of the results
comparing Eco RNAP and RNAP-DCTD (Figure 6C, lanes 2
and 3), disruption of the aCTD/UP-element interaction by gp67
is the best explanation for the appearance of cleavage sites
within the UP element with Sau RNAP in the presence of gp67
(Figure 6D, lane 6).
The DNase I footprint of SauRNAP (±gp67) on the gp67-insen-
sitive dnaA promoter shows qualitatively different features
compared with the footprints on the rrnA promoter. As with
rrnA, RNAP binding to the dnaA promoter induces DNase I
hypersensitivity at sites between the 10 and 35 elements; at
the dnaA promoter, these sites are at 27, 26, and to a lesser
extent25 (Figure 6C, lanes 7–9). RNAP binding (in the absence
of gp67) induces DNase I cleavage at the upstream edge of the
35 element that is not present without RNAP (Figure 6C,
compare lanes 7 and 8, band b). However, band b in this case1012 Cell 151, 1005–1016, November 21, 2012 ª2012 Elsevier Inc.is weak (relative to band a) compared with band b of the rrnA
footprints, which is very prominent (and stronger than band a).
Moreover, a DNase I cleavage site at approximately 46 is not
protected, suggesting that the aCTD binds weakly or not at all
to this region. The weak features upstream of band a are altered
in the presence of gp67; the weak band b cleavage is eliminated,
and new weak cleavage sites appear, likely reflecting the disrup-
tion of weak aCTD-DNA interactions.
Thus, the DNase I footprint of Sau RNAP on the gp67-insensi-
tive dnaA promoter does not show the distinctive features indic-
ative of strong aCTD/UP-element interactions, suggesting that
transcription from this promoter is not UP-element dependent.
In the presence of gp67, alterations in the cleavage pattern just
upstream of the 35 element indicate that gp67 is present in
the RNAP-holoenzyme/dnaA promoter complex, even though
gp67 has little to no effect on transcription output from this
promoter (Figures 3C and 6B).
We also determined DNase I footprints for the rrnA(upstream
dnaA) and dnaA(upstream rrnA) promoters (Figure S5B). On
the gp67-insensitive rrnA(upstream dnaA) promoter, the DNase
I cleavage pattern in the region upstream of the 35 element
suggests weak aCTD/UP-element interactions (i.e., dramatically
weakened hypersensitivity around 39, and distinct cleavage
sites between40 and56, where one would expect protection
due to aCTD binding). On the gp67-sensitive dnaA(upstream
rrnA) promoter, the DNase I cleavage pattern suggests
aCTD/UP-element interactions (increased hypersensitivity of
band b and protection through the upstream region), which are
altered in the presence of gp67.
DISCUSSION
Bacteriophages are the most abundant and diverse form of life
on Earth, and exert a major influence over the biosphere. The
complete genome sequences of >400 double-stranded DNA
phages have been determined. Metagenomic analyses have
shown that the phage population is dominated by genetic infor-
mation that is not related to known sequences (Bru¨ssow and
Hendrix, 2002). Bacteriophages are dependent upon a host
organism for propagation and have evolved ingenious mecha-
nisms to subvert host cellular processes (such as transcription)
for their own needs (Nechaev and Severinov, 2003). In addition
to elucidating new mechanisms of bacterial RNAP regulation,
the study of phage-encoded regulators can shed light on
RNAP function. One can argue that most basic principles of
cellular transcription regulation have been exploited by phages,
and that the study of phages has revealed many of these mech-
anisms (Ptashne, 1992).
The use of bacteriophages, including Sau-specific phages, for
the treatment or prophylaxis of bacterial infectious diseases is
experiencing a resurgence, increasing the need to understand
bacteriophage/host interactions. Identification and mechanistic
analysis of phage proteins that bind and inhibit essential host
enzymes can point to potential drug targets and mechanisms
(Liu et al., 2004).
Our work on Sau phage G1 gp67 has uncovered a novel regu-
latorymechanism (Figure 7). Upon its expression in the cell, gp67
forms a tight complex with sA4 (Figure 4A), but in a way that does
Figure 7. Model for gp67 Function
(A) At most 10/35 promoters, which are not dependent on aCTD/UP-
element interactions, gp67 joins the Sau RNAP holoenzyme through its inter-
action with sA4. However, gp67 does not block any of the functions of s
A
4 and
does not inhibit RNAP.
(B) At promoters where activity depends on aCTD/UP-element interactions,
gp67 joins the RNAP holoenzyme through its interaction with sA4 and inhibits
transcription initiation by preventing aCTD binding to the promoter-proximal
UP-element subsite, or to both proximal and distal subsites (shown).not block the two primary functions of sA4: core RNAP binding
(Figure 4B) and promoter 35 element recognition (Figure 4C).
Therefore, gp67 becomes a stable component of the RNAP holo-
enzyme (Figure S1B) and even of RNAP-holoenzyme/promoter
complexes. Nevertheless, the vastmajority (91%) of promoters
in Sau are unaffected by gp67 (Figure 3A). Rather than acting
as a general anti-s factor, gp67 inhibits Sau transcription in
a promoter-specific fashion by selectively targeting promoters
depending on the UP-element/RNAP aCTD interaction.
Approximately 90 Sau promoters are downregulated by
gp67, and 116 promoters are upregulated (Figures 2D and 3A).
Six of these in vivo downregulated promoters (rrnA, rrnB-P1,
rrnB-P2, csp1, csp2, and pstp; Figure S5A) have been tested
in vitro, and all six are directly downregulated by gp67 (Figures
2B and 3E). Based on this limited sample, we postulate that
gp67 directly inhibits most, if not all, of the promoters that are
downregulated by gp67 expression in vivo. We examined six
in vivo upregulated promoters in vitro, but did not observe any
evidence for direct, gp67-mediated stimulation. Therefore, we
cannot rule out the possibility that the observed in vivo upregu-
lation was an indirect effect of inhibition of rRNA transcription,
which would significantly increase the cellular concentration of
available RNAP (Barker et al., 2001).
Bacterial transcription initiation is often regulated by activator
proteins that typically bind DNA operators upstream of the core
promoter and contact the RNAP through the aCTD or through s4C(Browning and Busby, 2004). Thus, the mechanism of gp67-
mediated inhibition of transcription initiation at UP-element-
dependent promoters suggests the possibility that gp67 may
interfere with factor-dependent transcription activation as well,
a point that needs to be tested in future experiments.
Inhibition of Sau Cell Growth by gp67
To aid in the search for targets of small-molecule inhibitors, Xu
et al., (2010) identified a set of 308 genes required for Sau
growth. Among these were the rRNA genes that were shown
here to be directly inhibited by gp67 (Figure 2). In addition, seven
other genes inhibited by gp67 were required for cell growth in
Sau. Three of these are also required for translation (Table S3).
Recent work has shown that ribosomal protein promoters and
rRNA promoters are regulated by similar mechanisms (Lemke
et al., 2011). Given that all but four of the required genes down-
regulated by gp67 are required for a functional translational
machinery, and that cell growth is known to be limited by rRNA
synthesis (Gourse et al., 1996), the direct effect of gp67 on
rRNA expression specifically, and on expression of the transla-
tional machinery in general, is the likely mechanism through
which gp67 inhibits cell growth. Further experiments will be
required to determine whether gp67 inhibition of other genes
that are not involved in translation is sufficient to affect cell
growth.
Sau Transcription and Transcriptional Regulation
Previous studies examined transcription and its regulation
in vitro in Sau, but these studies focused on atypical, highly regu-
lated virulence promoters (Rao et al., 1995; Reyes et al., 2011).
Our analysis of gp67 function enabled us to identify sA-depen-
dent 10/35 promoters in Sau and to characterize Sau rRNA
promoters. The molecular tools developed here will be useful
for further studies of gene expression and its regulation in this
important pathogen. The native Sau transcription system (Sau
RNAP holoenzyme and Sau promoters) used here was critical
for elucidating the mechanism of gp67 inhibition, whereas the
use of a hybrid transcription system (Eco-core-RNAP/Sau-sA/
Eco-RNAP promoters) in previous work led to misleading results
(Dehbi et al., 2009).
Gp67 and rRNA Synthesis in Sau
The aCTD/UP-element interaction activates rRNA expression
by >100-fold in Eco and by roughly 3-fold in the Gram-positive
Bacillus subtilis (Kra´sny´ and Gourse, 2004). When gp67 is bound
to RNAP (suppressing UP-element function), or when the UP
element is removed from the Sau rRNA promoters in vitro, tran-
scription decreases 2- to 3-fold (Figure 6B), arguing that the UP-
element activation of rRNA transcription in Sau is more similar to
that in B. subtilis than that in Eco. In vivo, gp67 decreases
expression of rRNA promoters more dramatically (10-fold; Fig-
ure 2D), which may be explained by the competition for RNAP
binding between rRNA promoters and other promoters in the
genome.
rRNA synthesis is tightly regulated in prokaryotes and is
quickly inhibited upon the entry of bacteria into stationary phase
(growth-rate control; Haugen et al., 2008a). In Eco, growth-
rate control of rRNA synthesis involves several mechanisms,ell 151, 1005–1016, November 21, 2012 ª2012 Elsevier Inc. 1013
including direct modulation of the RNAP by the transcription
factor DksA and the small molecule ppGpp (Paul et al., 2004;
Perederina et al., 2004). Like DksA and ppGpp, gp67 is a tran-
scription regulator that interacts with RNAP at many promoters,
but affects transcriptional output from only a small subset of
these promoters due to their unique features. Gp67 specifically
takes advantage of the fact that full activity of the rRNA pro-
moters depends on UP-element utilization.
Role of gp67 in the Phage Life Cycle
The genomes of many Sau phages have been sequenced (Kwan
et al., 2005). The G1 phage is nearly identical to the Sau phage K
(Kwan et al., 2005), and gp67 shares 100% sequence identity
between these phages. Obvious gp67 homologs can be found
in five firmicute-specific phages. The molecular underpinnings
of these phages’ life cycles are largely unknown.
A consensus 10/35 promoter (with an extended 10
element) that is highly active with Sau RNAP in vitro (Figure S5C)
directs the synthesis of gp67, which is likely produced at high
levels early after initial injection of the double-stranded phage
genome into the host cell. We hypothesize that gp67 would
then engage with the host RNAP (Figure S1B) and suppress
production of rRNAs (Figure 2) by selectively inhibiting UP-
element-dependent promoters (Figure 6) while allowing tran-
scription from the majority of 10/35 promoters (Figure 3),
including its own promoter and other potential early phage
promoters that are resistant to gp67 inhibition (e.g., porf67
[Figure S5D] and porf05 [Figures 2A and 2B]). The phage ulti-
mately will require the use of host ribosomes to translate phage
gene products. Because rRNA is stable in prokaryotic cells
(Deutscher, 2003), previously formed ribosomes remain abun-
dant in Sau cells for hours after gp67 expression (Figures 2C
and 2D).
During log-phase growth, the majority of RNAP in prokaryotic
cells is occupied in actively transcribing rRNA. Inhibition of rRNA
transcription not only leads to arrest of cell division (Gourse et al.,
1996) but also frees a large pool of host RNAP that can then be
recruited to the strong phage early promoters. The T4 phage
anti-s factor, AsiA, inhibits host RNAP transcription of the host
genome by blocking35 element recognition while an additional
protein, MotA, recruits the AsiA-modified RNAP complex to
phage promoters (Hinton et al., 2005). The T4 phage has many
additional protein factors that suppress transcription of the
host genome and/or favor transcription of the phage genome
in a coordinated fashion, including enzymes that ADP-ribosylate
the RNAP aCTD, leading to inhibition of UP-element-dependent
promoters and recruitment of RNAP to phage promoters (Tie-
mann et al., 2004). The phage G1 genome does not encode its
own RNAP, but relies on the host RNAP for transcription during
its entire life cycle, which likely requires complex coordination
akin to that observed for phage T4. Therefore, although gp67
expression alone is sufficient to inhibit cell growth (Figure S3;
Dehbi et al., 2009; Liu et al., 2004), the existence of additional
phage proteins that control the host RNAP throughout the phage
life cycle seems likely; however, this remains to be determined.
Particularly interesting is the possibility that other phage proteins
directly cooperate with gp67 to promote regulated transcription
of the phage genome.1014 Cell 151, 1005–1016, November 21, 2012 ª2012 Elsevier Inc.EXPERIMENTAL PROCEDURES
Full details of the experimental procedures used in this work are presented in
the Extended Experimental Procedures.
Protein Expression and Purification
Gp67 or gp67/sA4 encoding sequences were cloned into pET-based expres-
sion vectors, transformed into Eco BL21(DE3) cells, and overexpressed, and
the proteins were purified using standard methods. The purified complex
was dialyzed into crystallization buffer (10 mM Tris-HCl, pH 8.0, 0.5 M NaCl)
and screened for crystallization conditions. Endogenous Sau RNAP was puri-
fied from NCTC8325 cells essentially as previously described (Deora and
Misra, 1996).
In Vitro Transcription Assays
In vitro transcription assays were performed using standard methods.
Genetic Analysis of the gp67/Sau-sA4 Interaction
A bacterial two-hybrid assay (Dove and Hochschild, 2004) was used to genet-
ically dissect the interaction between gp67 and Sau sA4. Taking advantage of
the fact that gp67 binds to Sau sA4 but not to Eco s
70
4, we made a series of
Eco/Sau s4 chimeras in order to define a minimal specificity-determining
region (Figure S1D). Having identified four amino acid differences within this
region that suffice to dictate whether or not gp67 can bind, we generated an
otherwise functional Sau sA4 mutant (bearing the corresponding Eco residues
at Sau positions 309, 312, 313, and 335) that did not interact with gp67. We
assessed the functional integrity of this mutant by using the two-hybrid assay
to test its ability to interact with the b-flap (Figure S1D), and a one-hybrid assay
to test its ability to bind a 35 element (data not shown).
Gp67 Expression In Vivo
Gp67was cloned into the Sau expression vector pRMC2 (Corrigan and Foster,
2009). pRMC2-gp67 or empty pRMC2 was then transformed into Sau strain
RN4220 by electroporation (Schenk and Laddaga, 1992). Cells were then
grown in trypticase soy (TS) broth containing chloramphenicol, and transgene
expression was induced with 100 ng/ml anhydrotetracycline.
RNA Purification and Metabolic Labeling
RNA was purified from cells at mid-log phase growth (OD600 0.3–0.4) using the
RNeasy kit from QIAGEN. In vivo labeling of nascent RNAs was carried out as
previously described (Wade et al., 1964).
RNA-seq: Sample Preparation, Sequencing, and Data Analysis
Samples were amplified onto flowcells using an Illumina cBot and sequenced
on an Illumina HiSeq2000 for 51 cycles according to the manufacturer’s proto-
cols. Raw sequencing data were processed using the onboard SCS/RTA soft-
ware, yielding 51 bp reads. Sequencing reads were processed using TopHat
(Trapnell et al., 2009). Alignments reported from TopHat were processed by
the Cufflinks software package (Trapnell et al., 2010) to determine differential
expression of genes and transcripts between conditions. Expression values
are reported as fragments per kilobase of gene per million mapped reads
(FPKM). Data were visualized using the Integrated Genomics Viewer (Robin-
son et al., 2011).
Crystallization of the gp67/sA4 Complex
Crystals of the gp67/sA4 complex were grown under two different conditions
at 22C. Form I crystals grew from a crystallization solution of 0.1 M 2-ethane-
sulfonic acid (MES), pH 6.5, 10% (w/v) polyethylene glycol (PEG) 5,000
monomethyl-ether, 20% 1-propanol. The crystals were soaked briefly in crys-
tallization solution supplemented with 15% glycerol and then flash-frozen in
liquid nitrogen. Form II crystals grew from a crystallization solution of 0.16 M
Ca-acetate, 0.08 M Na-cacodylate, 15% (w/v) PEG 8,000, 20% glycerol.
The crystals were flash-frozen in liquid nitrogen directly from themother liquor.
Crystals were formed using a 1:1 ratio of gp67/sA4 complex (10 mg/ml) and
reservoir solution. Selenomethionyl-substituted protein was purified and crys-
tallized under the same conditions.
Diffraction data were collected at the Advanced Photon Source (Argonne
National Laboratory) beamline NE-CAT 24 ID and the National Synchrotron
Light Source (Brookhaven National Laboratory) beamline X3A. Both structures
were solved by single wavelength anomalous diffraction, and refined against
the higher-resolution native data (Tables S1 and S2) to yield the final models.
DNase I Footprinting
DNase I footprinting was performed using standard methods.
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